Cargando…

Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro

Coronavirus disease 2019 (COVID-19) has been a pandemic disease of which the termination is not yet predictable. Currently, researches to develop vaccines and treatments is going on globally to cope with this disastrous disease. Main protease (3CLpro) from severe acute respiratory syndrome coronavir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Seri, Kim, Suwon, Kim, Dae Yong, Kim, Mi-Sun, Shin, Dong Hae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470085/ https://www.ncbi.nlm.nih.gov/pubmed/32746637 http://dx.doi.org/10.1080/14756366.2020.1801672

Ejemplares similares

Inhibition of SARS-CoV 3CL protease by flavonoids
por: Jo, Seri, et al.
Publicado: (2019)

A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors
por: Jo, Seri, et al.
Publicado: (2022)

A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2
por: Jo, Seri, et al.
Publicado: (2021)

Dimerization Tendency of 3CLpros of Human Coronaviruses Based on the X-ray Crystal Structure of the Catalytic Domain of SARS-CoV-2 3CLpro
por: Jo, Seri, et al.
Publicado: (2022)

The inhibitory activity of methoxyl flavonoids derived from Inula britannica flowers on SARS-CoV-2 3CLpro
por: Kim, Jang Hoon, et al.
Publicado: (2022)

Prediction of inhibitory constants of compounds against SARS-CoV 3CLpro enzyme with 2D-QSAR model
por: Yu, Xinliang
Publicado: (2021)

A study of Rose Bengal against a 2-keto-3-deoxy-d-manno-octulosonate cytidylyltransferase as an antibiotic candidate
por: Kim, Suwon, et al.
Publicado: (2020)

Progress on SARS-CoV-2 3CLpro Inhibitors: Inspiration from SARS-CoV 3CLpro Peptidomimetics and Small-Molecule Anti-Inflammatory Compounds
por: Zhu, Jiajie, et al.
Publicado: (2022)

A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors
por: Vankadara, Subramanyam, et al.
Publicado: (2021)

Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease
por: Kuang, Yi, et al.
Publicado: (2023)

Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro
por: Silva, Rai C., et al.
Publicado: (2021)

Inhibition of African swine fever virus protease by myricetin and myricitrin
por: Jo, Seri, et al.
Publicado: (2020)

GTP Preference of d-Glycero-α-d-manno-Heptose-1-Phosphate Guanylyltransferase from Yersinia pseudotuberculosis
por: Kim, Suwon, et al.
Publicado: (2019)

A study of inhibitors of d-glycero-β-d-manno-heptose-1-phosphate adenylyltransferase from Burkholderia pseudomallei as a potential antibiotic target
por: Kim, Suwon, et al.
Publicado: (2021)

Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro
por: Hou, Ningke, et al.
Publicado: (2023)

Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro
por: Hameedi, Mikhail Ali, et al.
Publicado: (2021)

Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds
por: Rizzuti, Bruno, et al.
Publicado: (2021)

Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro
por: Hameedi, Mikhail A., et al.
Publicado: (2022)

An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro
por: Liao, Qi, et al.
Publicado: (2021)

Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations
por: Grottesi, Alessandro, et al.
Publicado: (2020)

Development of a colorimetric assay for the detection of SARS-CoV-2 3CLpro activity
por: Garland, Gavin D., et al.
Publicado: (2022)

Potential SARS-CoV-2 3CLpro inhibitors from chromene, flavonoid and hydroxamic acid compound based on FRET assay, docking and pharmacophore studies
por: Hariono, Maywan, et al.
Publicado: (2021)

All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity
por: Morita, Takeshi, et al.
Publicado: (2021)

Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors
por: Ghosh, Arun K., et al.
Publicado: (2007)

Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening
por: Abian, Olga, et al.
Publicado: (2020)

BRET-Based Self-Cleaving Biosensors for SARS-CoV-2 3CLpro Inhibitor Discovery
por: Hou, Ningke, et al.
Publicado: (2022)

Reconstruction of the unbinding pathways of noncovalent SARS-CoV and SARS-CoV-2 3CLpro inhibitors using unbiased molecular dynamics simulations
por: Noroozi Tiyoula, Fereshteh, et al.
Publicado: (2022)

In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV
por: Udofia, Inemesit A., et al.
Publicado: (2021)

Oxidative stress transforms 3CLpro into an insoluble and more active form to promote SARS-CoV-2 replication
por: Du, Liubing, et al.
Publicado: (2021)

SARS-CoV-2 3CLpro whole human proteome cleavage prediction and enrichment/depletion analysis
por: Prescott, Lucas
Publicado: (2022)

Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitors
por: Paul, Abhik, et al.
Publicado: (2021)

The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper
por: Belenkaya, Svetlana V., et al.
Publicado: (2023)

Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
por: Mody, Vicky, et al.
Publicado: (2021)

Dimethyl sulfoxide reduces the stability but enhances catalytic activity of the main SARS‐CoV‐2 protease 3CLpro
por: Ferreira, Juliana C., et al.
Publicado: (2021)

Label-free duplex SAMDI-MS screen reveals novel SARS-CoV-2 3CLpro inhibitors
por: Scholle, Michael D., et al.
Publicado: (2022)

Key dimer interface residues impact the catalytic activity of 3CLpro, the main protease of SARS-CoV-2
por: Ferreira, Juliana C., et al.
Publicado: (2022)

Targeting 3CLpro and SARS-CoV-2 RdRp by Amphimedon sp. Metabolites: A Computational Study
por: Shady, Nourhan Hisham, et al.
Publicado: (2021)

A new glimpse on the active site of SARS-CoV-2 3CLpro, coupled with drug repurposing study
por: Novak, Jurica, et al.
Publicado: (2022)

Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper
por: Belenkaya, Svetlana V., et al.
Publicado: (2023)

Flavonoids against the SARS-CoV-2 induced inflammatory storm
por: Liskova, Alena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c4ps53igtme8oibrbgg5ggbf26